Articles

There’s a new twist in the ongoing debate over whether drugs widely used for weight loss are linked with thoughts of self-injury or suicide. 

Defensive stocks like consumer staples and utilities have recently come back in vogue, and that is making some investors nervous.

Lewis Altfest provided three examples of municipal bonds whose yields are way above those of U.S. Treasury notes of similar maturities on a taxable-equivalent basis.

Orders for recreational vehicles drop, but D.A. Davidson analyst sees REV Group and Shyft Group as buys.

FuelCell Energy said Tuesday it will hold a special meeting of shareholders to ask them to vote on a proposal that will allow the fuel-cell technology company to enact a reverse stock split.

GeoVax shares have been on a tear since the World Health Organization declared mpox a public-health emergency of international concern.

The Federal Reserve will use its Jackson Hole retreat to outline to markets a gradual easing plan beginning at its mid-September meeting, economists said, ahead of the two days of discussions that will start Friday.

Eli Lilly’s stock gained more than 2% premarket on Tuesday after the drugmaker said that tirzepatide, marketed as the diabetes drug Mounjaro and weight-loss treatment Zepbound, sharply cut patients’ risk of developing Type 2 diabetes in a late-stage trial.

While one analyst said latest deal could help AMD “potentially close the gap” with Nvidia over several years, another said the move still “doesn’t level the playing field.”

The device, which can be inserted through a minimally invasive catheter-based procedure, received FDA Breakthrough Device Designation in 2019 and has the potential to become the first device of its kind to market, Johnson & Johnson said.

The European Commission said it plans to place a 9% tariff on Tesla imports — down from a previously proposed tariff of above 20%.

Harris has not proposed sweeping price controls — on food, rents or anything else.